選單 研討會快訊 最新醫療快訊 藥物安全警訊 學會行事曆 Frontline IO-Combos, Next-Generation ADCs: Evolutions in Endometrial Cancer 2026-03-31 查看更多 New Companion Diagnostic Wins FDA Approval FDA Approves Companion Diagnostic for Pembrolizumab in Esophageal/GEJ Carcinoma Durvalumab/SBRT May Limit Tumor Progression in Early-Stage NSCLC Videos Trending 2026-03-31 查看更多 Optimizing Therapeutic Strategies Across Treatment Lines in Advanced RCC 2026-03-31 查看更多 Sunvozertinib Shows Benefit in NSCLC Trial Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC Defining Molecular Pathways Across Neuroendocrine Disease States Videos Trending 2026-03-25 查看更多 TRANSFORM + Long-Term Follow-Up ASH 2025 Insights: Durability, Survival, and Safety Updates Featured Video 2026-03-20 查看更多 Bispecific Antibodies vs CAR T-Cells: Mechanistic and Practical Distinctions Featured Video 2026-03-18 查看更多 Mipletamig Combo Shows Activity in AML Mipletamig Combo Produces Robust Activity in Newly Diagnosed AML Rolling NDA Submission Completed for Zipalertinib in EGFR+ NSCLC Videos Trending 2026-03-14 查看更多 T-DXd Wins FDA Priority Review FDA Grants Priority Review to T-DXd in HER2+ Early Breast Cancer FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC Videos Trending 2026-03-12 查看更多 123
